Kwangdong Healthbio광동헬스바이오
086220 · KONEX · ₩086220 · 광동헬스바이오
- Market cap
- ₩15B
- Enterprise value
- ₩33B
- P/E
- —
- P/B
- 0.8×
- Dividend yield
- 0.0%
- ROE
- −3.5%
- Net margin
- −1.0%
Trailing 12 months from filed financial statements, as of FY 2025. Dividend yield: the 2025 dividend per share from the annual report ÷ today's price.
52-week range−31.4% from the high
₩600Today: ₩1,011 – ₩1,179₩1,719
Returns
- 1W−8.5%
- 1M+7.4%
- 3M+32.6%
- 6M−14.6%
- YTD−25.1%
- 1Y−7.5%
- Volume today
- 47
- 0.2× the 20-day average
- Traded today
- ₩49,807
- Listed shares
- 12,687,865
- EPS (12 months)
- −₩51
- Earnings yield −4.3%
🎁 Gift this stock
Send a friend ₩100,000 of paper money in this stock. They get it when they join.
Signals
Quiet- BuzzQuietBuzz 27 of 100 (50 is a normal day for this stock).
- MomentumStrong18.1% over the last month; the price is above its 20-day average.
Signals describe activity, not recommendations. Not financial advice.
Kwangdong Healthbio stock overview
Kwangdong Healthbio (광동헬스바이오, KRX: 086220) is listed on KONEX, in the Food & Beverage sector. The company manufactures and exports health functional foods and develops functional food ingredients and pharmaceutical raw materials, operating under a business founded in 1992. Its shares closed at ₩1,179 on Oct 30, 2026, down 0.84% on the day, giving it a market value of ₩15B.
Key facts
- Market cap
- ₩15B
- Sector
- Food & Beverage
- Latest price change
- −0.84%
- As of
- Oct 30, 2026
- Main business
- The company manufactures and exports health functional foods and develops functional food ingredients and pharmaceutical raw materials, operating under a business founded in 1992.
Quick answers about Kwangdong Healthbio
- What does Kwangdong Healthbio do?
- The company manufactures and exports health functional foods and develops functional food ingredients and pharmaceutical raw materials, operating under a business founded in 1992. Its products are mainly sold to business customers on an OEM/ODM basis, produced in various forms such as liquids, granules, powders and soft capsules, including red ginseng, probiotic, and vitamin-based products. Its main production facilities are located in Cheongju, Chungcheongbuk-do, and it also sells to overseas markets.
- What is the market cap of Kwangdong Healthbio?
- The market capitalisation of Kwangdong Healthbio was ₩15B at the close on Oct 30, 2026.
- Who are the largest shareholders of Kwangdong Healthbio?
- According to the latest official filings, the largest reported holders are Kwangdong Pharmaceutical (65.61%, as of Nov 6, 2025); BL Pharmtech (13.96%, as of Jul 13, 2026).
- When is the next earnings report from Kwangdong Healthbio?
- Korean companies rarely announce results dates in advance. Based on when Kwangdong Healthbio filed the same report in past years, its next annual results is expected between Mar 16, 2027 and Mar 19, 2027.
Company profile
The company manufactures and exports health functional foods and develops functional food ingredients and pharmaceutical raw materials, operating under a business founded in 1992. Its products are mainly sold to business customers on an OEM/ODM basis, produced in various forms such as liquids, granules, powders and soft capsules, including red ginseng, probiotic, and vitamin-based products. Its main production facilities are located in Cheongju, Chungcheongbuk-do, and it also sells to overseas markets.
Written by AI from the company's latest annual report.
- Korean name
- 광동헬스바이오
- Sector
- Food & Beverage
- Themes
- K-food & ramen
- CEO
- 정 화 영
- Founded
- Dec 1992
- Listed
- Jul 2015
- Listed shares
- 12,687,865
- Fiscal year ends
- Month 12
- Website
- www.kdhealthbio.com
Similar companies
- Samyang Foods003230 · ₩8.6T₩1,138,000−0.35%
- Orion271560 · ₩4.5T₩114,800+1.68%
- CJ Cheiljedang097950 · ₩2.6T₩173,200+1.11%
- Nongshim004370 · ₩2.4T₩397,500+2.45%
- Otoki007310 · ₩1.3T₩317,500+0.95%
- Hite Jinro000080 · ₩1.1T₩15,940+2.18%
- Lotte Wellfood280360 · ₩1.1T₩117,100−0.43%
- Lotte Chilsung Beverage005300 · ₩933B₩100,500+3.72%
Recent filings
See all- Investor relations (IR) eventOct 6, 2026
- Investor relations (IR) eventSep 18, 2026
- 5%+ holding reportJul 21, 2026
- Insider shareholding reportJul 13, 2026
- 5%+ holding reportJul 13, 2026
Titles in Korean until English translations are added.
Also known as: Kwangdong Healthbio / 광동헬스바이오 / 086220 / KRX:086220
Source: KRX statistical information